Company page
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. is a public company traded under the ticker MDGL in the American market. The company has a market capitalization of approximately $12.76 billion. Madrigal focuses on developing innovative therapies for liver and metabolic diseases.
- Ticker
- MDGL:NASDAQ
- Asset type
- Stock
- Market cap
- $12.33B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD